Charmacy Pharmaceutical Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Charmacy Pharmaceutical Co Ltd with three other
drug stores in Asia:
Jiangsu Nhwa Pharmaceutical Company Limited
sales of 3.86 billion Chinese Renmimbi [US$543.54 million]
of which 63%
was Medical Industrial Manufacturing),
(2.38 billion Malaysian Ringgits [US$569.74 million]
of which 71%
was Operating Segment- Logistics and Distrib), and
Zhejiang Zhenyuan Co., Ltd.
based in China
(2.86 billion Chinese Renmimbi [US$402.64 million]
of which 77%
was Medicine Wholesales).
During the year ended December of 2018, sales at
Charmacy Pharmaceutical Co Ltd were HK$4.65 billion (US$593.02 million).
decrease of 1.8%
versus 2017, when the company's sales were HK$4.74 billion.